Spanish NPO Calls to Prohibit Sale of Disposable E-cigarettes to Protect Children

Regulations by 2FIRSTS.ai
Mar.07.2024
Spanish NPO Calls to Prohibit Sale of Disposable E-cigarettes to Protect Children
Spanish non-profit organization Nofumadores.org urges government action to ban disposable e-cigarettes to protect children from tobacco industry influence.

According to the Spanish European news agency, the non-profit organization Nofumadores.org is calling on the government to urgently take action to ban the sale of disposable e-cigarettes in order to protect children from the influence of the tobacco industry. This move aligns with policies that have already been implemented or planned in some other countries.

 

The president of the Nofumadores.org association, Raquel Fernández Megina, questioned in a statement why the government is still hesitant to ban the sale of these harmful devices that have already become present on school playgrounds.

 

The association urges the government to clarify its position as soon as possible and to legislate to ban the sale of disposable e-cigarettes, including those marketed as "nicotine-free" products, because "the majority of e-cigarettes sold online contain this addictive substance".

 

The association chairman warned, "Every day that these devices are still being sold on the market, there are thousands of young people starting to be exposed to nicotine, potentially leading to a lifelong addiction that will be difficult to break.

 

According to a 2023 survey conducted by Estudes on adolescent behavioral addiction, nearly 23% of girls aged 12 to 14 and over 19% of boys have used e-cigarettes in the past 12 months.

 

The survey also highlighted that 46% of teenagers aged 14 to 18 have used these devices, with girls being affected more significantly.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ireland’s Tobacco and Vape Retail Licensing Regime Takes Effect; BAT Says It Should Cover Nicotine Pouches
Ireland’s Tobacco and Vape Retail Licensing Regime Takes Effect; BAT Says It Should Cover Nicotine Pouches
Ireland’s retail licensing system took effect on Feb. 2, 2026, charging annual fees per point of sale and enforced by the Health Service Executive (HSE). British American Tobacco’s local unit, BAT Ireland, said excluding nicotine pouches could leave a regulatory gap.
Feb.04 by 2FIRSTS.ai
BAT Japan Announces McLaren Collaboration “glo Hilo Plus” Limited-Edition Set, Priced at About USD 200
BAT Japan Announces McLaren Collaboration “glo Hilo Plus” Limited-Edition Set, Priced at About USD 200
British American Tobacco Japan (BAT Japan) announced a collaboration with McLaren Racing to launch the “glo Hilo Plus・McLaren Racing Inspired Limited-Edition Set.” Sales begin on March 3 via the glo Store Ginza and the official glo online store. Based on the “glo Hilo Plus,” the set includes a limited-edition device and dedicated accessories, priced at JPY 30,000 (about USD 200).
Mar.03 by 2FIRSTS.ai
Malaysia’s Selangor health authorities fine company US$5,000 over toy-like vape devices
Malaysia’s Selangor health authorities fine company US$5,000 over toy-like vape devices
Selangor’s health department said a company was fined RM20,000(US$5,000) for supplying vape devices designed to resemble toys. Officers raided the firm’s premises near Taman Kosas in Ampang on Dec 19, 2025 after discovering it was importing and distributing toy-shaped vape devices.
Mar.05 by 2FIRSTS.ai
PMI reports full-year 2025 results with net revenues of $40.6 billion and smoke-free net revenues were about $16.9 billion
PMI reports full-year 2025 results with net revenues of $40.6 billion and smoke-free net revenues were about $16.9 billion
Philip Morris International (PMI) released its Q4 and full-year 2025 results on February 6, 2026. PMI reported full-year net revenues of $40,648 million ($40.6 billion), reported diluted EPS of $7.26 and adjusted diluted EPS of $7.54. PMI said smoke-free net revenues were $16.9 billion and represented 41.5% of total net revenues, with smoke-free products available in 106 markets and over 43 million estimated adult consumers.
Feb.06 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Special Report | China’s New Five-Year Plan Highlights “Health-First” Strategy, Providing Policy Context for Tobacco Sector
Special Report | China’s New Five-Year Plan Highlights “Health-First” Strategy, Providing Policy Context for Tobacco Sector
China’s 2026 “Two Sessions” reviewed the draft Outline of the 15th Five-Year Plan, which proposes implementing a health-first development strategy and strengthening the effectiveness of the Patriotic Health Campaign. Although the document does not address specific industries, this public-health governance framework provides a new policy context for observing the future regulation, product strategies, and market development of China’s tobacco and next-generation nicotine sectors.
Industry Insight
Mar.08